← Eichor
Study identifier: NCT05569161 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

To Evaluate the Safety and Clinical Radiological Outcomes in 2 Years of Embrance Model Reverse Shoulder Arthroplasty

Condition: Implantation of a Reverse Shoulder Prosthesis  ·  Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

PhaseN/A
Planned participants250
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The use of inverted prostheses to replace shoulder joints damaged by degenerative or traumatic processes has become widespread over the past three decades. Current designs, used correctly, can restore function and improve pain in the majority of patients in whom they are implanted. The aim is to carry out a more detailed follow-up of the subjects who are implanted with this prosthetic model on a primary basis, analysing the clinical and radiological results and evaluating the presence of adverse effects of the prosthesis or short-term complications. For this purpose, subjects will be closely monitored for two years.

This description comes directly from the study's public registry record.

Talk to the study team

Miguel Ángel Ruiz Iban, MD, PhD  ·  655668479  ·  drmri@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Miguel Ángel Ruiz IbánMadrid, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05569161